KIAA1210

Across TCGA pan-cancer cohorts, KIAA1210 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated KIAA1210 data layer compared with 10 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in small cell lung cancer (SCLC), where higher KIAA1210 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA1210 expression acts as an unfavorable survival marker, although some lineages such as SCLC and KIRC show a favorable association.

SCLC, BLCA, and KIRC are the cancer types where KIAA1210 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	DFS	Median	All	0.604	0.355	.003	52	view →
BLCA	OS	Tertile	II,III,IV	0.283	0.590	.003	45	view →
KIRC	DFS	Median	All	0.863	0.761	.001	44	view →
LIHC	DFS	Quartile	II,III,IV	0.247	0.568	.004	44	view →
LUAD	DFS	Median	All	0.839	0.710	.003	39	view →
UCEC	DFS	Quartile	IV	0.876	0.365	.018	24	view →
READ	DFS	Tertile	All	0.446	0.750	.007	22	view →
ACC	OS	Tertile	All	0.703	1.000	.002	18	view →
PRAD	DFS	Quartile	All	0.902	0.754	.008	18	view →
OV	DFS	Median	III,IV	0.406	0.336	.016	16	view →
UVM	OS	Tertile	All	0.417	0.822	.004	14	view →
MESO	OS	Quartile	II,III,IV	0.538	0.703	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

KIAA1210–SCLC (DFS)

Open the SCLC breakdown →